Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × atezolizumab × Gastrointestinal × Clear all

Phase

Status

Sponsor Class

OTHER 91 INDUSTRY 64 NIH 8 OTHER_GOV 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Lymphoid 1 Gynecologic 1 Genitourinary 1 Gastrointestinal 1 Dermatologic 1 Breast 1

Conditions

Esophageal Neoplasms 1 Biliary Tract Neoplasms 1

Interventions

Fluorouracil 74 Leucovorin 48 Oxaliplatin 44 Cisplatin 40 Capecitabine 39 Gemcitabine 37 Radiotherapy 30 Irinotecan 28 Cetuximab 21 Paclitaxel 15 Bevacizumab 12 Docetaxel 10 Taxes 9 durvalumab 8 dehydroftorafur 8 Mitomycin 8 Surgical Procedures, Operative 7 Platinum 7 Folfox protocol 7 Carboplatin 7 Albumin-Bound Paclitaxel 7 130-nm albumin-bound paclitaxel 7 Specimen Handling 6 S 1 (combination) 6 Panitumumab 6 Watchful Waiting 5 Imatinib Mesylate 5 Gene Expression Profiling 5 Epirubicin 5 tremelimumab 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03818997 2020-02-05

DYNAMIC

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Withdrawn

Gastrointestinal

Biliary Tract Neoplasms, Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡